Enlight Biosciences forms new partnerships with AstraZeneca and Novo Nordisk
Thursday, 15 December 2011
This partnership reflects AstraZeneca’s commitment to accessing and fostering innovation that exists outside of our own labs
Enlight Biosciences LLC announced today that it has formed new partnerships with AstraZeneca and Novo Nordisk. As partners in Enlight, AstraZeneca and Novo Nordisk will have the opportunity to collaborate and invest in the development of potentially transformational technologies with application to their therapeutic programs.
Enlight was created by PureTech Ventures in partnership with major pharmaceutical companies and academic luminaries to proactively address critical unmet industry needs.